Atossa Therapeutics Inc (NASDAQ:ATOS)
| 0.8079 Delayed Data As of Jan 26 |  -0.0265 / -3.16%Today’s Change | 0.50 Today|||52-Week Range 1.62 | +52.87% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 4.0M | 3.1M | 7.3M | 10.5M | |
| Short Term Investment Cash | -4.5M | -907.9K | 4.2M | 3.2M | ||
| Cash & Short Term Investments | 4.0M | 3.1M | 7.3M | 10.5M | ||
| Receivables | Receivables | 0.00 | 0.00 | 358.3K | 518.1K | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Prepaid Expenses | 193.3K | 157.4K | 236.7K | 493.1K | |
| Other Current Assets | 110.7K | 14.2K | 30.6K | 47.7K | ||
| Current Assets | 4.3M | 3.3M | 7.9M | 11.5M | ||
| Total Assets | Property, Plant and Equipment - Gross | 285.9K | 210.5K | 170.9K | 216.0K | |
| Depreciation | -114.3K | -155.4K | -159.5K | -161.5K | ||
| Intangible Assets | 1.7M | 640.4K | 75.7K | 99.4K | ||
| Other Assets | 1.8M | 834.7K | 254.6K | 116.6K | ||
| Total Assets | 6.2M | 4.1M | 8.2M | 11.7M | ||
| Liabilities | Accounts Payable | 814.4K | 0.00 | 334.9K | 353.3K | |
| Accrued Expenses | 463.7K | 17.0K | 90.1K | 177.1K | ||
| Other Current Liabilities | 621.6K | 343.4K | 105.6K | 217.0K | ||
| Other Liabilities | 2.5M | 1.0M | 1.2M | 2.9M | ||
| Total Liabilities | Total Liabilities | 2.5M | 1.0M | 1.2M | 2.9M | |
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 2.4M | ||
| Common Equity | 3.7M | 3.1M | 6.9M | 6.4M | ||
| Total Shareholder Equity | 3.7M | 3.1M | 6.9M | 8.8M | ||
| Share Information | Common Shares Outstanding | 181.4K | 315.6K | 2.7M | 5.8M | |
| Addtl. Info. | No data currently available for this section. | |||||
